NONSMALL CELL LUNG CANCER
Clinical trials for NONSMALL CELL LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new NONSMALL CELL LUNG CANCER trials appear
Sign up with your email to follow new studies for NONSMALL CELL LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New radioactive drug takes aim at Hard-to-Treat cancers
Disease control Recruiting nowThis early-phase trial tests a new drug that delivers radiation directly to cancer cells carrying a specific protein called GRPR. The study includes 48 adults with advanced cancers like prostate, breast, lung, or colon cancer that have not responded to standard treatments. The ma…
Matched conditions: NONSMALL CELL LUNG CANCER
Phase: PHASE1 • Sponsor: Orano Med Theranostics, SAS • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
Can we treat sicker lung cancer patients the same as healthier ones?
Disease control Recruiting nowThis study looks at whether non-small cell lung cancer patients who are less fit (performance status 2) can be treated just as effectively with a combination of chemotherapy and immunotherapy as those who are more fit (performance status 0-1). About 105 participants will receive …
Matched conditions: NONSMALL CELL LUNG CANCER
Phase: PHASE2 • Sponsor: Wake Forest University Health Sciences • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
New hope for lung cancer: first human trial of DZD6008 begins
Disease control Recruiting nowThis early-stage trial tests a new drug called DZD6008 in about 190 people with advanced non-small cell lung cancer that has a specific EGFR mutation. The main goals are to check the drug's safety and see if it can shrink tumors. Because this is the first time the drug is given t…
Matched conditions: NONSMALL CELL LUNG CANCER
Phase: PHASE1 • Sponsor: Dizal Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
New program aims to ease distress for advanced lung cancer patients
Symptom relief Recruiting nowThis study is testing a new program called POISE for people with stage IV non-small cell lung cancer who are on targeted therapy. The program includes four visits with a specially trained palliative care clinician to help patients cope with uncertainty and manage their cancer. Re…
Matched conditions: NONSMALL CELL LUNG CANCER
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 07:59 UTC
-
AI takes on lung cancer: can a computer match a Doctor's wisdom?
Knowledge-focused Recruiting nowThis study tests whether an artificial intelligence (AI) model can help doctors make better treatment decisions for non-small cell lung cancer (NSCLC). About 300 patients will have their treatment plans created by both a standard team of doctors and the AI. Researchers will compa…
Matched conditions: NONSMALL CELL LUNG CANCER
Phase: NA • Sponsor: Wen-zhao ZHONG • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:03 UTC